Insider Trades43 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Sell | NKTR | Jonathan Zalevsky | Chief R&D Officer | 5,681 | $70.00 | $2.4B | -36.00% | +108.86% | $397.7K | -36.80% | — | Stalk |
| Jun 16, 2026 | Sell | NKTR | Howard W Robin | President & CEO | 20,000 | $60.75 | $2.4B | -36.00% | +108.86% | $1.2M | -7.42% | — | Stalk |
| Jun 15, 2026 | Sell | NKTR | Jonathan Zalevsky | Chief R&D Officer | 5,538 | $60.71 | $2.4B | -36.00% | +108.86% | $336.2K | -26.40% | — | Stalk |
| May 19, 2026 | Sell | NKTR | Jonathan Zalevsky | Chief R&D Officer | 199 | $65.51 | $2.4B | -36.00% | +108.86% | $13.0K | -0.94% | — | Stalk |
| May 19, 2026 | Sell | NKTR | Howard W Robin | President & CEO | 444 | $65.51 | $2.4B | -36.00% | +108.86% | $29.1K | -0.59% | — | Stalk |
| Feb 18, 2026 | Sell | NKTR | Jonathan Zalevsky | Chief R&D Officer | 180 | $73.00 | $2.4B | -36.00% | +108.86% | $13.1K | -0.84% | — | Stalk |
| Feb 18, 2026 | Sell | NKTR | Howard W Robin | President & CEO | 423 | $73.00 | $2.4B | -36.00% | +108.86% | $30.9K | -0.56% | — | Stalk |
| Jan 20, 2026 | Sell | NKTR | Jonathan Zalevsky | Chief R&D Officer | 3,867 | $35.67 | $2.4B | -36.00% | +108.86% | $137.9K | -15.33% | — | Stalk |
| Nov 25, 2025 | Sell | NKTR | Mark Andrew Wilson | Chief Legal Officer | 630 | $54.28 | $2.4B | -36.00% | +108.86% | $34.2K | -2.46% | — | Stalk |
| Nov 25, 2025 | Sell | NKTR | Jonathan Zalevsky | Chief R&D Officer | 1,157 | $54.28 | $2.4B | -36.00% | +108.86% | $62.8K | -4.65% | — | Stalk |
| Nov 25, 2025 | Sell | NKTR | Howard W Robin | President & CEO | 2,207 | $54.28 | $2.4B | -36.00% | +108.86% | $119.8K | -3.22% | — | Stalk |
| Sep 9, 2025 | Sell | NKTR | Howard W Robin | President & CEO | 6,666 | $46.69 | $2.4B | -36.00% | +108.86% | $311.2K | -3.13% | — | Stalk |
| Sep 4, 2025 | Sell | NKTR | Jonathan Zalevsky | Chief R&D Officer | 1,721 | $33.52 | $2.4B | -36.00% | +108.86% | $57.7K | -2.35% | — | Stalk |
| Sep 4, 2025 | Sell | NKTR | Howard W Robin | President & CEO | 11,832 | $36.42 | $2.4B | -36.00% | +108.86% | $431.0K | -2.68% | — | Stalk |
| Sep 2, 2025 | Sell | NKTR | Jonathan Zalevsky | Chief R&D Officer | 485 | $30.10 | $2.4B | -36.00% | +108.86% | $14.6K | -2.47% | — | Stalk |
| Sep 2, 2025 | Sell | NKTR | Howard W Robin | President & CEO | 1,500 | $30.16 | $2.4B | -36.00% | +108.86% | $45.2K | -2.16% | — | Stalk |
| Aug 19, 2025 | Sell | NKTR | Mark Andrew Wilson | Chief Legal Officer | 676 | $26.59 | $2.4B | -36.00% | +108.86% | $18.0K | -1.58% | — | Stalk |
| Aug 19, 2025 | Sell | NKTR | Jonathan Zalevsky | Chief R&D Officer | 725 | $26.59 | $2.4B | -36.00% | +108.86% | $19.3K | -1.96% | — | Stalk |
| Aug 19, 2025 | Sell | NKTR | Howard W Robin | President & CEO | 1,573 | $26.59 | $2.4B | -36.00% | +108.86% | $41.8K | -1.00% | — | Stalk |
| May 19, 2025 | Sell | NKTR | Mark Andrew Wilson | Chief Legal Officer | 9,996 | $0.67 | $2.4B | -36.00% | +108.86% | $6.7K | -3.08% | — | Stalk |
| May 19, 2025 | Sell | NKTR | Jonathan Zalevsky | Chief R&D Officer | 10,712 | $0.67 | $2.4B | -36.00% | +108.86% | $7.2K | -3.38% | — | Stalk |
| May 19, 2025 | Sell | NKTR | Howard W Robin | President & CEO | 23,208 | $0.67 | $2.4B | -36.00% | +108.86% | $15.5K | -2.14% | — | Stalk |
| Feb 19, 2025 | Sell | NKTR | Jonathan Zalevsky | Chief R&D Officer | 10,300 | $1.01 | $2.4B | -36.00% | +108.86% | $10.4K | -3.15% | — | Stalk |
| Feb 19, 2025 | Sell | NKTR | Mark Andrew Wilson | Chief Legal Officer | 11,040 | $1.01 | $2.4B | -36.00% | +108.86% | $11.2K | -3.29% | — | Stalk |
| Feb 19, 2025 | Sell | NKTR | Howard W Robin | President & CEO | 23,774 | $1.01 | $2.4B | -36.00% | +108.86% | $24.0K | -2.14% | — | Stalk |
| Dec 23, 2024 | Sell | NKTR | Mark Andrew Wilson | Chief Legal Officer | 49,962 | $0.90 | $2.4B | -36.00% | +108.86% | $44.8K | -6.78% | — | Stalk |
| Dec 19, 2024 | Sell | NKTR | Jonathan Zalevsky | Chief R&D Officer | 51,115 | $0.94 | $2.4B | -36.00% | +108.86% | $48.0K | -13.52% | — | Stalk |
| Dec 17, 2024 | Sell | NKTR | Howard W Robin | President & CEO | 132,030 | $1.00 | $2.4B | -36.00% | +108.86% | $131.6K | -5.41% | — | Stalk |
| Nov 19, 2024 | Sell | NKTR | Mark Andrew Wilson | Chief Legal Officer | 6,407 | $1.01 | $2.4B | -36.00% | +108.86% | $6.5K | -2.84% | — | Stalk |
| Nov 19, 2024 | Sell | NKTR | Jonathan Zalevsky | Chief R&D Officer | 7,785 | $1.01 | $2.4B | -36.00% | +108.86% | $7.9K | -3.10% | — | Stalk |
| Nov 19, 2024 | Sell | NKTR | Howard W Robin | President & CEO | 16,278 | $1.01 | $2.4B | -36.00% | +108.86% | $16.4K | -1.92% | — | Stalk |
| Aug 19, 2024 | Sell | NKTR | Mark Andrew Wilson | Chief Legal Officer | 5,651 | $1.28 | $2.4B | -36.00% | +108.86% | $7.2K | -2.45% | — | Stalk |
| Aug 19, 2024 | Sell | NKTR | Jonathan Zalevsky | Chief R&D Officer | 6,866 | $1.28 | $2.4B | -36.00% | +108.86% | $8.8K | -2.66% | — | Stalk |
| Aug 19, 2024 | Sell | NKTR | Howard W Robin | President & CEO | 14,881 | $1.28 | $2.4B | -36.00% | +108.86% | $19.0K | -1.72% | — | Stalk |
| May 17, 2024 | Sell | NKTR | Mark Andrew Wilson | Chief Legal Officer | 6,260 | $1.75 | $2.4B | -36.00% | +108.86% | $11.0K | -2.64% | — | Stalk |
| May 17, 2024 | Sell | NKTR | Jonathan Zalevsky | Chief R&D Officer | 7,355 | $1.75 | $2.4B | -36.00% | +108.86% | $12.9K | -2.78% | — | Stalk |
| May 17, 2024 | Sell | NKTR | Howard W Robin | President & CEO | 16,650 | $1.75 | $2.4B | -36.00% | +108.86% | $29.1K | -1.89% | — | Stalk |
| Feb 20, 2024 | Sell | NKTR | Mark Andrew Wilson | Chief Legal Officer | 7,606 | $0.68 | $2.4B | -36.00% | +108.86% | $5.2K | -3.11% | — | Stalk |
| Feb 20, 2024 | Sell | NKTR | Jonathan Zalevsky | Chief R&D Officer | 9,014 | $0.68 | $2.4B | -36.00% | +108.86% | $6.1K | -3.29% | — | Stalk |
| Feb 20, 2024 | Sell | NKTR | Howard W Robin | President & CEO | 20,033 | $0.68 | $2.4B | -36.00% | +108.86% | $13.6K | -2.23% | — | Stalk |
| Nov 17, 2023 | Sell | NKTR | Mark Andrew Wilson | Chief Legal Officer | 7,179 | $0.49 | $2.4B | -36.00% | +108.86% | $3.5K | -2.86% | — | Stalk |
| Nov 17, 2023 | Sell | NKTR | Jonathan Zalevsky | Chief R&D Officer | 9,646 | $0.49 | $2.4B | -36.00% | +108.86% | $4.7K | -3.40% | — | Stalk |
| Nov 17, 2023 | Sell | NKTR | Howard W Robin | President & CEO | 19,877 | $0.49 | $2.4B | -36.00% | +108.86% | $9.7K | -2.16% | — | Stalk |